Showing results (121-130 of 274) with videos related to
Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for advanced esophagogastric cancer: dose-finding study for the prospective multicenter, randomized, phase II/III REAL-3 trialAlicia F C Okines, Sue E Ashley, David Cunningham, et al.Current Oncology (Toronto, Ont.)|September 26, 2025
Clinical and Molecular Profiling of Colorectal Cancer: A Comprehensive Cohort Study of BRAF-Mutated Cases from a Tertiary CentreJulia Freckelton, Justin Mencel, Iris Levink, et al.British Journal of Cancer|March 25, 2023
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trialsAvani Athauda, Matthew Nankivell, Rupert Langer, et al.The Lancet. Oncology|January 29, 2010
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trialYu Jo Chua, Yolanda Barbachano, David Cunningham, et al.Clinical Colorectal Cancer|November 15, 2016
Attitudes of Patients With Gastrointestinal Cancers Toward Research BiopsiesSing Yu Moorcraft, Ruwaida Begum, David Cunningham, et al.Current Problems in Cancer|March 5, 2019
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature reviewVasiliki Michalarea, Elisa Fontana, Alvaro Ingles Garces, et al.Annals of Surgery|September 17, 2020
MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal CancerAmy C Lord, Nigel D'Souza, Annabel Shaw, et al.Annals of Hematology|October 26, 2013
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphomaEliza A Hawkes, Sarah Barton, David Cunningham, et al.Clinical Nuclear Medicine|March 6, 2015
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasisHenry H Tam, Gary J Cook, Ian Chau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancerIan Chau, Gina Brown, David Cunningham, et al.Pageof 28